Search Results 331-340 of 16347 for anti-TNF drugs

  1. 'Virtual clinical trials' may predict success of heart failure drugs

    Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most ...

  2. An Extension Study Monitoring the Safety of Patients with Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... Use of TNF antagonists;; Use of antagonists of ... Use of anti-adhesion molecules (e.g., anti-MAdCAM-1).

  3. Antidepressants: Get tips to cope with side effects - Mayo Clinic

    If insomnia is an ongoing problem, ask your doctor about taking a sedating medication at bedtime or ask whether taking a low dose of a sedating antidepressant ...

  4. A Study to Identify a Panel of Biomarkers to Predict Response to Anti PD-1 Therapy - Mayo Clinic

    The purpose of this study is to identify a panel of possible biomarkers to predict response to anti PD-1 therapy by establishing the progression free survival ...

  5. Evaluation of CRS-207 With Pembrolizumab in Previously Treated MPM - Mayo Clinic

    The purpose of this study is to evaluate whether CRS-207 with pembrolizumab is safe and effective in adults with MPM who have failed prior anti-cancer therapy.

  6. Brentuximab (intravenous route) - Side effects & uses - Mayo Clinic

    Brentuximab injection is also used together with other medicines (eg, lenalidomide, rituximab) to treat certain types of large B-cell lymphoma (including ...

  7. Tailored Antiplatelet Therapy Following PCI - Mayo Clinic

    Clopidogrel is an anti-platelet medication approved by the U.S. Federal Drug Administration (FDA) for use in patients who undergo Percutaneous Coronary ...

  8. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Mayo Clinic

    Unstable biological therapy (e.g., TNF-α (anti-tumor necrosis factor), natalizumab, etc.), including significant changes in doses or switch of drug within 6 ...

  9. Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL - Mayo Clinic

    Being treated with anti-TNF therapies or has been treated with an anti-TNF therapy within 5 half-lives of randomization. Participating Mayo Clinic locations.

  10. A Study to Evaluate the Effectiveness and Safety of Oral OPS-2071 in Subjects With Crohn's Disease Showing Symptoms of Active Inflammation - Mayo Clinic

    By condition, treatment or drug name ... [TNF-α] monoclonal antibody), immunosuppressants ... Subjects taking any nonsteroidal anti-inflammatory drugs that cannot be ...